Literature DB >> 21649655

Serotonin depletion leads to cortical hyperexcitability and trigeminal nociceptive facilitation via the nitric oxide pathway.

Supang Maneesri le Grand1, Weera Supornsilpchai, Chonlawan Saengjaroentham, Anan Srikiatkhachorn.   

Abstract

OBJECTIVE: To investigate the role of nitric oxide (NO) in the development of cortical hyperexcitability and trigeminal nociceptive facilitation induced by serotonin (5-HT) depletion.
BACKGROUND: Nitric oxide and 5-HT are important in the pathogenesis of primary headaches. An increase in cortical excitability and trigeminal nociception has been demonstrated in animals with low 5-HT levels. Although the mechanism underlying this increase is unclear, an alteration of the NO system is one possible explanation.
METHODS: Male Wistar rats were divided into control and 5-HT-depleted groups. 5-HT was depleted by i.p. injection of parachlorophenylalanine (100 mg/kg). Three days after injection, a microelectrode was inserted into the cerebral cortex for electrocorticograph recording and waves of cortical spreading depression (CSD) were triggered with KCl application. N-nitro-L-arginine methyl ester (L-NAME; 10 mg/kg by i.v. injection) or saline was given after the second CSD wave. Following the experiment, the cerebral cortex and brain stem were removed for anti-neuronal nitric oxide synthase (nNOS) and anti-Fos immunohistochemistry.
RESULTS: Relative to the control group, the 5-HT-depleted group exhibited a higher frequency of CSD waves, more nNOS-immunoreactive cells in both the cerebral cortex and brainstem and more Fos-immunoreactive cells in the trigeminal nucleus caudalis (TNC). In the control group, L-NAME application led to fewer nNOS-immunoreactive cells in the cerebral cortex and TNC, and fewer Fos-immunoreactive cells in the TNC; however, L-NAME was without effect on the CSD pattern. By contrast, in addition to decreased nNOS and Fos expression, L-NAME significantly reduced the frequency of CSD events in the 5-HT-depleted group.
CONCLUSIONS: Inhibition of NO production can counter both the cortical hyperexcitability and facilitation of trigeminal nociception that develop in the depleted 5-HT state. Therefore, NO is likely involved in the increase in both CSD events and CSD-evoked trigeminal nociception under decreased 5-HT conditions.
© 2011 American Headache Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21649655     DOI: 10.1111/j.1526-4610.2011.01931.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  12 in total

Review 1.  Pathophysiology of medication-overuse headache: implications from animal studies.

Authors:  Saknan Bongsebandhu-phubhakdi; Anan Srikiatkhachorn
Journal:  Curr Pain Headache Rep       Date:  2012-02

Review 2.  Medication-overuse headache: epidemiology, diagnosis and treatment.

Authors:  Espen Saxhaug Kristoffersen; Christofer Lundqvist
Journal:  Ther Adv Drug Saf       Date:  2014-04

3.  Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers.

Authors:  Matthew W Johnson; R Andrew Sewell; Roland R Griffiths
Journal:  Drug Alcohol Depend       Date:  2011-11-29       Impact factor: 4.492

4.  [Classification and therapy of medication-overuse headache: impact of the third edition of the International Classification of Headache Disorders].

Authors:  H Göbel; K Heinze-Kuhn; I Petersen; C Göbel; A Göbel; A Heinze
Journal:  Schmerz       Date:  2014-04       Impact factor: 1.107

Review 5.  Emotional Problems in Pediatric Headache Patients.

Authors:  Hideki Shimomura
Journal:  Curr Pain Headache Rep       Date:  2022-03-28

Review 6.  The Evolution of Medication Overuse Headache: History, Pathophysiology and Clinical Update.

Authors:  Christina Sun-Edelstein; Alan M Rapoport; Wanakorn Rattanawong; Anan Srikiatkhachorn
Journal:  CNS Drugs       Date:  2021-05-17       Impact factor: 5.749

Review 7.  Medication-overuse headache: a review.

Authors:  Espen Saxhaug Kristoffersen; Christofer Lundqvist
Journal:  J Pain Res       Date:  2014-06-26       Impact factor: 3.133

Review 8.  Genetic and biochemical changes of the serotonergic system in migraine pathobiology.

Authors:  Claudia Francesca Gasparini; Robert Anthony Smith; Lyn Robyn Griffiths
Journal:  J Headache Pain       Date:  2017-02-13       Impact factor: 7.277

Review 9.  The need for new acutely acting antimigraine drugs: moving safely outside acute medication overuse.

Authors:  Willem Sebastiaan van Hoogstraten; Antoinette MaassenVanDenBrink
Journal:  J Headache Pain       Date:  2019-05-16       Impact factor: 7.277

10.  Vagus nerve stimulation inhibits cortical spreading depression.

Authors:  Shih-Pin Chen; Ilknur Ay; Andreia Lopes de Morais; Tao Qin; Yi Zheng; Homa Sadeghian; Fumiaki Oka; Bruce Simon; Katharina Eikermann-Haerter; Cenk Ayata
Journal:  Pain       Date:  2016-04       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.